NGHLF.US Nightingale Health Oyj
- Market cap
- USD 97.8M
- P/E
- -
- P/B
- 1.81x
- ROE
- -37.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is NGHLF.US undervalued?
Graham numberThe Graham number of Nightingale Health Oyj cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nightingale Health Oyj fundamental analysis
No fundamental analysis for Nightingale Health Oyj yet.
Nightingale Health Oyj stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nightingale Health Oyj
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, Europe, the Middle East, Africa, AMER, and the Asia-Pacific. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely, as well as multiomics analysis services. It provides its services to research programs, universities, and healthc…
Full company profileNightingale Health Oyj financial statements
Nightingale Health Oyj annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 2.31M | 2.31M | 4.18M | 4.36M | 4.69M | 5.50M |
| Gross Profit | 1.99M | 1.28M | 3.59M | 2.90M | 3.54M | 2.84M |
| Operating Income | -8.77M | -13.7M | -18.7M | -18.6M | -19.4M | -18.8M |
| EBITDA | - | - | -11.4M | -8.42M | -10.1M | -11.6M |
| Net Income | -9.73M | -16.1M | -18.1M | -17.5M | -18.5M | -18.5M |
| EPS | -0.16 | -0.27 | -0.30 | -0.29 | -0.31 | -0.31 |
| Balance Sheet | ||||||
| Total Assets | 139M | 124M | 107M | 90.8M | 74.5M | 58.1M |
| Total Liabilities | 15.9M | 12.6M | 9.44M | 7.96M | 8.35M | 9.32M |
| Shareholders' Equity | 123M | 111M | 97.4M | 82.9M | 66.2M | 48.7M |
| Cash & Short-term Investments | 114M | 95.3M | 80.6M | 43.7M | 41.3M | 36.8M |
| Cash Flow | ||||||
| Operating Cash Flow | -1.87M | -7.47M | -7.33M | -8.41M | -10.1M | -10.9M |
| Capital Expenditure | 3.33M | 7.61M | 4.41M | 4.59M | 4.15M | 2.22M |
| Free Cash Flow | -5.20M | -15.1M | -11.7M | -13.0M | -14.3M | -13.1M |
| Ratios | ||||||
| ROE | -7.9% | -14.4% | -18.6% | -21.1% | -27.9% | -37.9% |
| ROA | -7.0% | -13.0% | -16.9% | -19.2% | -24.8% | -31.8% |
| Net Profit Margin | -421.9% | -695.7% | -432.4% | -400.7% | -393.4% | -335.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Nightingale Health Oyj dividends
Nightingale Health Oyj has not paid dividends in the last 6 fiscal years.
Who owns Nightingale Health Oyj
- Insiders 33.57%
- Institutions 7.32%
- Public & others 59.12%
- Shares outstanding 40.6M
- Free float 29.8M
Nightingale Health Oyj company profile
- Company name
- Nightingale Health Oyj
- Ticker
- NGHLF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Information Services
- Employees
- 101
- Fiscal year end
- June
- Address
- Mannerheimintie 164a, Helsinki, Finland, 00300
- Phone
- 358 207301810
- Website
- nightingalehealth.com
About Nightingale Health Oyj
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, Europe, the Middle East, Africa, AMER, and the Asia-Pacific. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely, as well as multiomics analysis services. It provides its services to research programs, universities, and healthcare providers. The company has a collaboration with Personalised Health Clinics to incorporate the company's metabolomic blood testing into Personalised Health Clinics' personalized, clinician-led healthcare services. Nightingale Health Oyj was incorporated in 2002 and is based in Helsinki, Finland.
Nightingale Health Oyj management
10- Mr. Teemu SunaFounder, Interim CFO, CEO & Director · born 1982
- Mr. Antti KangasFounder, CTO & Director · born 1984
- Ms. Satu SaksmanCo-Founder & Chief Commercial Officer of APAC · born 1976
- Mr. Peter Wurtz Ph.D.Founder & Scientific Director
- Mr. Pasi Soininen Ph.D.Founder & Laboratory Director
- Ms. Janna RantaCOO and Chief Commercial Officer of Research & Healthcare · born 1985
- Ms. Satu Sirén-LähdeahoGeneral Counsel
- Ms. Minja SalmioChief Commercial Officer of EMEA Region · born 1987
- Ms. Salla Ruosaari Ph.D.Chief Research & Development Officer · born 1976
- Dr. Charles AlessiChief Clinical Officer